Chiral Drugs Book PDF, ePub eBook

Join our eBook service for unlimited books & audiobooks. Get a free 7 day subscription! ↓↓↓↓↓


Book Descriptions:
In the early twentieth century the relevance of chirality to the pharmaceutical industry was established by the fact that one enantiomer of hyoscyamine possessed greater pharmacological activity than the other.

Today, most new drugs and those under development consist of a single optically active isomer, and chirality is also becoming an issue for the agrochemical and other industries. Regulatory agencies throughout the world are currently reviewing the importance of chirality with regard to pharmaceutical and agrochemical products. New guidelines from such agencies have been key drivers for the focus on single enantiomer products in these industries.

These scientific and regulatory developments have created the need for a guide for workers in the pharmaceutical and chemical industries seeking information on chiral molecules, processes, and commercially available chiral chemicals. Chiral Drugs is a comprehensive listing of over 2500 chiral drugs, classified by therapeutic class, and including structures and physical properties for each entry in the listing. Its companion volume, Chiral Intermediates, presents the same detailed information for over 4700 commercially available chiral chemicals.

The 'Chiral Pool' of readily available, relatively inexpensive chiral compounds has been expanding at a rapid rate as more and more products are produced in large quantities at economical prices. New developments in various technologies for isolating, preparing, and purifying chiral materials have greatly increased the opportunities for utilizing optically pure compounds in commercial applications. Novel techniques for classical resolution, new methodologies for developing selective enzymes for biocatalysis, advances in the application of microorganisms for chemical production, and continued progress in the area of asymmetric synthesis have all contributed to the growth of this field.

Part One of each book contains four chapters which provide an introduction to topics relevant to the field of chiral chemistry and includes a brief overview of chirality, a short discussion on the current market drivers in the area of chiral chemistry, and a basic presentation of the various sources and methods for obtaining chiral compounds.

Part Two presents entries for over 2500 chiral drugs, classified by therapeutic class. For each main entry, the chemical name and a list of trade names and synonyms is provided; the CAS Registry Number, the European Inventory of Existing Commercial Chemical Substances (EINECS) number, and the Merck Index (12th edition) number are given when available. The physical properties, including specific rotation, of each compound are described and indicated applications are presented. The structure of nearly every compound is provided, and the manufacturers and suppliers of the compounds are also given. Indexes, including a master index of names and synonyms and an index of custom manufacturing services for production of chiral compounds, are appended.

Chiral Drugs provides an introduction to the types of sources and methods currently in use for obtaining chiral molecules and is an invaluable resource for researchers in the pharmaceutical and biotechnology sectors as well as to those working in the basic biochemical sciences. Chiral Intermediates provides an introduction to the types of sources and methods currently in use for obtaining chiral molecules and is an invaluable resource for information on available chiral molecules. Chiral Intermediates and Chiral Drugs are the most comprehensive and detailed guides to chiral compounds available.

Chiral Drugs by Cynthia A. Challener

From reader reviews:

Jim Martin:

Reading a guide can be one of a lot of pastime that everyone in the world likes. Do you like reading book so. There are a lot of reasons why people like it. First reading a book will give you a lot of new data. When you read a e-book you will get new information simply because book is one of various ways to share the information or maybe their idea. Second, studying a book will make an individual more imaginative. When you reading a book especially hype book the author will bring one to imagine the story how the characters do it anything. Third, you may share your knowledge to some others. When you read this Chiral Drugs, you are able to tells your family, friends along with soon about yours e-book. Your knowledge can inspire the others, make them reading a publication.

Becky Duncan:

Are you kind of hectic person, only have 10 or even 15 minute in your day to upgrading your mind expertise or thinking skill perhaps analytical thinking? Then you are receiving problem with the book in comparison with can satisfy your short period of time to read it because all this time you only find publication that need more time to be read. Chiral Drugs can be your answer because it can be read by a person who have those short extra time problems.

Melinda Brown:

Is it an individual who having spare time then spend it whole day by simply watching television programs or just resting on the bed? Do you need something new? This Chiral Drugs can be the response, oh how comes? A fresh book you know. You are thus out of date, spending your extra time by reading in this completely new era is common not a geek activity. So what these books have than the others?

Alice Prahl:

Publication is one of source of understanding. We can add our information from it. Not only for students but additionally native or citizen will need book to know the change information of year for you to year. As we know those books have many advantages. Beside all of us add our knowledge, may also bring us to around the world. By book Chiral Drugs we can consider more advantage. Don't you to definitely be creative people? To become creative person must want to read a book. Only choose the best book that acceptable with your aim. Don't be doubt to change your life at this time book Chiral Drugs. You can more attractive than now.